Skip to main content

MedCloud Minute

Blog archive

cliexa and OpiSafe Partner on AI Platform for Opioid Stewardship and Behavioral Health

Key Takeaways

  • Cliexa and OpiSafe launch an AI-powered platform for opioid stewardship and behavioral health management.
  • Solution combines OUD risk prediction, opioid tapering support, and treatment referral coordination.
  • Integrated analytics and automation help clinicians improve patient outcomes, care coordination, and compliance.

cliexa, an AI-powered clinical intelligence company, and OpiSafe, a leader in opioid prescribing, monitoring, and stewardship technologies, have announced a strategic partnership to deliver an AI-powered platform focused on opioid stewardship and behavioral health management. The joint offering is designed to help healthcare providers identify patients at risk, monitor treatment plans, and support interventions related to opioid use and mental health conditions.

The platform combines clinical analytics, workflow automation and patient engagement capabilities to provide a more comprehensive view of patient care. By integrating opioid stewardship and behavioral health data, the system is intended to assist clinicians with care coordination, risk assessment and regulatory reporting requirements.

The cliexa-OpiSafe partnership brings together three core capabilities including AI-powered OUD risk prediction, opioid tapering management, and treatment referral and care coordination. Together, these capabilities create a unified workflow that supports patients from risk identification through intervention, treatment coordination, and long-term management.

Posted by MedCloudInsider Editors on 06/16/2026